Search By Initial

Cas Index 2

• 244240-24-2 | LFM-A13 (Catalog# : 20438)LFM-A13 is a potent and selective inhibitor of Bruton's tyrosine kinase (BTK). LF
• 2375815-63-5 | LY-3475070 (Catalog# : 21244)LY-3475070 is a potent and selective CD73 Inhibitor with IC50 of 28 nM. LY3475070 Alo
• 2097938-59-3 | Lerociclib HCl (G1T38 HCl) (Catalog# : 2073106)Lerociclib HCl (G1T38)is a novel, selective,differentiated oral CDK4/6 inhibitor with
• 2055050-87-6 | LAU159 (Catalog# : 2071505)LAU159 is a potent modulator of α6β3γ2 GABAA receptor.
• 294623-49-7 | L006235 (Catalog# : 2061307)L006235 is a potent, reversible cathepsin K inhibitor (IC50 = 0.25 nM) that displays
• 2274819-46-2 | LUT-014 (Catalog# : 2042701)LUT-014 is a B-Raf Inhibitor. Leveraging the paradoxical effect of B-Raf Inhibitors,
• 2135600-76-7 | LSZ102 (Catalog# : 2041502)LSZ102 is a potent ERα antagonist and degrader. LSZ102 showed ERα degradation IC50
• 2173037-97-1 | LY2794193 (Catalog# : 193262)LY2794193 is a highly potent and selective mGlu3 receptor agonist.
• 2166616-75-5 | LY-3381916 (Catalog# : 193123)LY-3381916 is a potent, selective and brain penetrated inhibitor of IDO1 activity, bi
• 245075-84-7 | LR-90 (Catalog# : 19364)LR-90 is an advanced glycation end product (AGE) inhibitor, inhibits inflammatory res
• 2222755-14-6 | LOXO-292 (Catalog# : 192195)LOXO-292 (ARRY-192) is an oral and selective investigational drug in clinical develop
• 292632-98-5 | L685458 (Catalog# : 186156)L685458 is a potent and selective γ -secretase inhibitor.
• 2097002-61-2 | LOXO-195 (Catalog# : 185212)LOXO-195 is a potent and selective TRK inhibitor capable of addressing potential mech
• 2088939-99-3 | LYN-1604 (Catalog# : 18493)LYN-1604 is a novel activator of ULK1, inducing cell death involved in ATF3, RAD21, a
• 226929-39-1 | LB42708 (Catalog# : 18443)LB42708 is a potent, orally active and selective nonpeptidic farnesyltransferase inhi
• 2040291-27-6 | LLY-283 (Catalog# : 184314)LLY-283 is a potent and selective SAM-competitive chemical probe for PRMT5.
• 231277-92-2 | Lapatinib (Catalog# : 17022807)Lapatinib(GW-572016) is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 n
• 27262-47-1 | Levobupivacaine free base (Catalog# : 16123031)Levobupivacaine is a local anaesthetic drug belonging to the amino amide group. It is
• 2070014-90-1 | LY 303511 hydrochloride (Catalog# : 611819)LY303511 Hcl, an inactive analogue of LY294002, is a mTOR inhibitor that did not inhi
• 253863-00-2 | L-778123 hydrochloride (Catalog# : 121805)L-778123 hydrochloride is an inhibitor of FPTase and GGPTase-I with IC50 of 2 nM and
• 248281-84-7 | Laquinimod (Catalog# : 121506)Laquinimod is an experimental immunomodulator developed by Active Biotech and Teva.
• 244240-24-2 | LFM-A13 (Catalog# : 52206)Selective Bruton's tyrosine kinase (BTK) inhibitor (IC50 = 2.5 M). Also inhibits poli
• 2925330-18-1 | MAT2A-IN-22 (Catalog# : 26A021)MAT2A-IN-22 (Compound 29-1) is a blood-brain barrier-penetrant and orally active MAT2
• 2925324-58-7 | MAT2A-IN-23 (Catalog# : 25210)MAT2A-IN-23 39 is a potent MTA2A inhibitor.
• 2271348-04-8 | MK256 (Catalog# : 25208)MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downreg
• 2957874-18-7 | MAT2A inhibitor 5 (Catalog# : 25204)MAT2A inhibitor 5 has a high potency for inhibiting MAT2A and a remarkable selectivit
• 2750895-97-5 | MTX115325 (Catalog# : 186264)MTX115325 is a potent, selective, brain-penetrant USP30 inhibitor with good drug-like
• 2439277-80-0 | MAT2A-IN-9 ( GSK4362676 ) (Catalog# : 25147)MAT2A-IN-9 ( GSK4362676 ), is a 2-oxoquinazoline derivative, is a potent MAT2A (methi
• 2769008-22-0 | MEN-1703 (Catalog# : 25143)
• 228113-66-4 | Maralixibat Chloride (Catalog# : 25126)Maralixibat (also known as SHP625, LUM001, and lopixibat) is an ileal bile acid trans